Jan Skvarka
CIK 1838042 · President and CEO · last filed 2025-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$776.8K
Companies
3
Total Filings
13
Lifetime Open-Market Net
-$1.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-19 | — | Disp (D) | — | $0 | |
| 2021-05-13 | Trillium Therapeutics Inc. (TRIL) Delisted | Mixed | — | -$1.15M | EDGAR |
| 2021-01-15 | Trillium Therapeutics Inc. (TRIL) Delisted | Mixed | — | -$365.1K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.